The Zucker Institute supports MUSC innovations at every stage of the technology transfer lifecycle—from early invention and evaluation through intellectual property protection, licensing, product development, and real-world use. Over multiple fiscal years, this end-to-end approach has enabled a steady flow of discoveries into startups, licensed technologies, and products on the market. By combining early engagement with inventors, strategic IP management, and active industry outreach, the Zucker Institute helps ensure promising ideas are positioned for successful commercialization and long-term impact. Together, these metrics reflect the scale and consistency of MUSC’s innovation pipeline and the Zucker Institute’s role in translating research into public benefit, economic growth, and improved patient care.